race trials new zantrene drug for extramedullary acute myeloid leukaemia (emd aml) – animation
Published 1 year ago • 671 plays • Length 0:36Download video MP4
Download video MP3
Similar videos
-
5:40
race oncology ltd advances zantrene aml trials
-
8:00
race oncology highlights impressive bisantrene clinical data
-
8:22
race oncology starts world-first cancer trial to treat rare form of leukaemia
-
1:56
race oncology featured on nbn news
-
6:42
race oncology looks to accelerate clinical development of bisantrene
-
5:00
race oncology secures governance approval for open-label zantrene trial
-
4:33
maintenance and continuous treatment in acute myeloid leukemia
-
5:40
race oncology discusses clinical progress and march quarter highlights
-
2:45
acute myeloid leukemia aml animation
-
1:44
what is race oncology?
-
0:54
what is aml acute myeloid leukemia? #aml
-
5:10
race oncology receives fda orphan drug designation extension for bisantrene rc220
-
10:15
acute myeloid leukemia | clinical presentation
-
5:20
race oncology (asx:rac) leukemia drug candidate update
-
0:05
chronic myeloid leukemia en
-
1:14:27
major treatment decisions for patients with acute myeloid leukemia (aml)
-
2:28
where do clinical trials fit into an aml treatment plan?
-
1:00
how long does someone live with aml? #cancer #leukemia #aml #aml